Back
Galmed Pharmaceuticals Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
7
GLMD
Galmed Pharmaceuticals
Last Price:
2.90
Seasonality Move:
13.88%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLMD is experiencing selling pressure, which indicates risk of future bearish movement.
Galmed Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3 | Sell |
| 20-day SMA: | 3.51 | Sell |
| 50-day SMA: | 4.72 | Sell |
| 200-day SMA: | 4.26 | Sell |
| 8-day EMA: | 3.07 | Sell |
| 20-day EMA: | 3.43 | Sell |
| 50-day EMA: | 3.99 | Sell |
| 200-day EMA: | 7.08 | Sell |
Galmed Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 39.04 | Sell |
| Chaikin Money Flow: | -19608 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.01 - 4.09) | Sell |
| Bollinger Bands (100): | (2.42 - 5.86) | Sell |
Galmed Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Galmed Pharmaceuticals Stock
Is Galmed Pharmaceuticals Stock a Buy?
- Galmed Pharmaceuticals share price is 2.93 while GLMD 8-day simple moving average is 3.00, which is a Sell signal.
- The stock price of GLMD is 2.93 while Galmed Pharmaceuticals 20-day SMA is 3.51, which makes it a Sell.
- Galmed Pharmaceuticals 50-day simple moving average is 4.72 while GLMD share price is 2.93, making it a Sell technically.
- GLMD stock price is 2.93 and Galmed Pharmaceuticals 200-day simple moving average is 4.26, creating a Sell signal.
GLMD Technical Analysis vs Fundamental Analysis
Sell
7
Galmed Pharmaceuticals (GLMD)
is a Sell
Is Galmed Pharmaceuticals a Buy or a Sell?
-
Galmed Pharmaceuticals stock is rated a Sell
The current Galmed Pharmaceuticals [GLMD] share price is $2.93. The Score for GLMD is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Galmed Pharmaceuticals Stock Info
Market Cap:
1.89M
Price in USD:
2.93
Share Volume:
33.61K
Galmed Pharmaceuticals 52-Week Range
52-Week High:
23.80
52-Week Low:
2.73
Sell
7
Galmed Pharmaceuticals (GLMD)
is a Sell
Galmed Pharmaceuticals Share Price Forecast
-
What is the Galmed Pharmaceuticals stock price today?
The Galmed Pharmaceuticals stock price is 2.93 USD today. -
Will GLMD stock go up or go down?
Galmed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Galmed Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galmed Pharmaceuticals is overvalued.
Is Galmed Pharmaceuticals Stock a Buy?
- Galmed Pharmaceuticals share price is 2.93 while GLMD 8-day exponential moving average is 3.07, which is a Sell signal.
- The stock price of GLMD is 2.93 while Galmed Pharmaceuticals 20-day EMA is 3.43, which makes it a Sell.
- Galmed Pharmaceuticals 50-day exponential moving average is 3.99 while GLMD share price is 2.93, making it a Sell technically.
- GLMD stock price is 2.93 and Galmed Pharmaceuticals 200-day simple moving average is 7.08, creating a Sell signal.
Fundamental Analysis of Galmed Pharmaceuticals
Is Galmed Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
Technical Analysis of Galmed Pharmaceuticals
Should I short Galmed Pharmaceuticals stock?
- GLMD Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Galmed Pharmaceuticals is a Sell
- Galmed Pharmaceuticals Relative Strength Index (RSI) is 39.04, which suggest Galmed Pharmaceuticals is oversold
- The Bollinger Bands (25) for Galmed Pharmaceuticals is (3.01 - 4.09), which suggest Galmed Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Galmed Pharmaceuticals is (2.42 - 5.86), which suggest Galmed Pharmaceuticals is a Sell
* Galmed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.